Report of Foreign Issuer (6-k)
November 14 2017 - 4:09PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 6-K
Report
of Foreign Private Issuer
Pursuant
to Rule 13
A
-16 or 15
d
-16 of
The
Securities Exchange Act of 1934
For the month of
November 2017
COMMISSION
FILE Number.
000-29338
CARDIOME PHARMA CORP.
(Translation of registrant’s name
into English)
1441 Creekside Drive, 6th floor
Vancouver, British Columbia, V6J 4S7,
CANADA
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will
file annual reports under cover Form 20-F or Form 40-F
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
¨
Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
¨
DOCUMENTS INCLUDED AS PART OF THIS REPORT
Exhibit
|
|
Description
|
|
|
|
99.1
|
|
Management’s Discussion and Analysis of Financial Condition and Results of Operations
|
99.2
|
|
Consolidated Financial Statements
|
99.3
|
|
Material Change Report Dated November 14, 2017
|
99.4
|
|
Certificate of Filing - CEO
|
99.5
|
|
Certificate of Filing - CFO
|
Exhibits 99.1, 99.2, 99.3, 99.4 and 99.5 are incorporated by
reference into the Registration Statement on Form F-10 of the Registrant (File No. 333-209606) and the Registration Statements
on Form S-8 of the Registrant (File No. 333-199091 and File No. 333-199092).
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
|
CARDIOME PHARMA CORP.
|
|
|
(Registrant)
|
|
|
|
|
|
Date: November 14, 2017
|
By:
|
/s/ Justin Renz
|
|
|
|
Name: Justin Renz
|
|
|
|
Title: Chief Financial Officer
|
|
Correvio Pharma (NASDAQ:CORV)
Historical Stock Chart
From Mar 2024 to Apr 2024
Correvio Pharma (NASDAQ:CORV)
Historical Stock Chart
From Apr 2023 to Apr 2024